FEMASYS INC (FEMY): Nasdaq/NYSE listing notice — Femasys receives Nasdaq delisting notice for MVLS below $35M; 180-day cure period until Nov 2025

FEMASYS INC

Nasdaq notified Femasys MVLS of common stock was below $35M minimum for 30 consecutive business days.
Femasys also fails alternative listing standards: stockholders' equity <$2.5M or net income <$500k.
Company has 180 calendar days, until November 17, 2025, to regain compliance.
No immediate effect on listing; Femasys will monitor MVLS and consider options to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

FEMASYS INC received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

May 19, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that for the last 30 consecutive business days, the Market Value of Listed Securities (“MVLS”) for the Company’s common stock was below the minimum $35.0 million requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “Minimum MVLS Requirement”). Additionally, the Company does not meet either of the alternative Nasdaq continued listing standards under Nasdaq Listing Rule 5550(b)(2): (i) stockholders’ equity of at least $2.5 mill

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

FEMASYS INC filing history →

Source: SEC EDGAR

accession 0001140361-25-020363

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.